Table 1. Laboratory results from the initial visit and subsequent visits.
| Laboratory tests | Normal reference values | On admission | 28 days On the steroid azathioprine | 42 days Azathioprine discontinued and rituximab initiated | 56 days | 84 days | 112 days | 168 days | 365 days |
|---|---|---|---|---|---|---|---|---|---|
| Erythrocyte Sedimentation Rate | 0/15 mm/hour | 7 | |||||||
| C-Reactive Protein | ≤ 9 mg/L | < 2.90 | < 2.90 | ||||||
| Creatinine Kinase | 26-192 U/L | 15,000 | 2,040 | 1,300 | 989 | 837 | 132 | 114 | 96 |
| Aspartate Aminotransferase | 10-40 U/L | 309 | 86 | 47 | 29 | 20 | 20 | ||
| Alanine Aminotransferase | 12-78 U/L | 691 | 447 | 151 | 49 | 38 | 36 | ||
| Total Bilirubin | 0-1.5 mg/dL | 0.4 | 0.4 | 0.6 | 0.4 | 0.4 | 0.3 | ||
| Myoglobin | 9-83 ng/mL | > 1000 | |||||||
| Thyroid-stimulating Hormone | 0.4-5 uIU/mL | 2.124 | 2.330 | ||||||
| Carcinoembryonic Antigen | Negative | ||||||||
| Myositis-specific Antibodies | Negative | ||||||||
| CA-19-9 | Negative | ||||||||
| CA 125 | Negative | ||||||||
| Rheumatoid Factor | < 15 IU/mL | < 10 | |||||||
| Antinuclear Antibody | Negative | ||||||||
| Aldolase | 1.5-8 U/L | 135 | 63.6 | 6.1 |